Day One Biopharmaceuticals Inc (DAWN)

Day One Biopharmaceuticals Inc (DAWN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Apr 24, 2026: market cap $2.2B; returns 1 week +0.3%, 1 year +172.5%.

Day One Biopharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing targeted therapies for life-threatening diseases in patients of all ages, with a foundational emphasis on pediatric oncology.

DAWN financial model: income statement, cash flow and balance sheet